{"denoms":[{"counts":[{"groupId":"BG000","value":"77"}],"units":"Participants"}],"groups":[{"description":"pemetrexed: 500 mg/m2, intravenous, every 21 days x 4 cycles cisplatin: 75 mg/m2, intravenous, every 21 days x 4 cycles chemotherapy, surgery then chest radiation x 54 gray (Gy)","id":"BG000","title":"Pemetrexed"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.38","value":"61.1"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"56"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"77"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Stage IA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Stage IB"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"}]}],"title":"Stage II"},{"categories":[{"measurements":[{"groupId":"BG000","value":"35"}]}],"title":"Stage III"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Stage IV"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Unknown/Not Available"}],"paramType":"NUMBER","title":"Disease Stage at Time of Study Entry","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"28"}]}],"title":"0 - Fully active and asymptomatic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"47"}]}],"title":"1 - Ambulatory with symptoms"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"2 - In bed < 50% of time"}],"paramType":"NUMBER","title":"Eastern Cooperative Oncology Group Performance Status","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"62"}]}],"title":"Epithelial Mesothelioma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Mixed Cell Mesothelioma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Sarcomatoid Mesothelioma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Initial Pathological Diagnosis","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"71"}]}],"title":"Caucasian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"African"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"East/Southeast Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Western Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Hispanic"}],"paramType":"NUMBER","title":"Race/Ethnicity","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"2.909","value":"2.19"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Time from Initial Pathological Diagnosis to Enrollment","unitOfMeasure":"months"}]}